Compare AIZ & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIZ | MDGL |
|---|---|---|
| Founded | 1892 | 2011 |
| Country | United States | United States |
| Employees | 14800 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 12.1B |
| IPO Year | N/A | 2005 |
| Metric | AIZ | MDGL |
|---|---|---|
| Price | $236.84 | $513.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $256.83 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 284.7K | 249.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 41.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $180,133,000.00 |
| Revenue This Year | $7.39 | $58.39 |
| Revenue Next Year | $5.52 | $48.55 |
| P/E Ratio | $12.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $183.39 | $265.00 |
| 52 Week High | $246.31 | $615.00 |
| Indicator | AIZ | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 53.02 |
| Support Level | $232.08 | $503.93 |
| Resistance Level | $245.03 | $539.17 |
| Average True Range (ATR) | 4.26 | 15.73 |
| MACD | 1.18 | -3.53 |
| Stochastic Oscillator | 93.80 | 38.62 |
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.